Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service.

In a state-funded health care system individuals with a rare inherited cancer predisposition syndrome are generally able to access appropriate surveillance and patient management is improved compared to historical data. The "real world" data from this study will inform the future development of VHL management protocols.